Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis.

Sabya Sachi Das, Priyanshu Bharadwaj, Muhammad Bilal, Mahmood Barani, Abbas Rahdar, Pablo Taboada, Simona Bungau, George Z Kyzas
Author Information
  1. Sabya Sachi Das: Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand 835215, India. ORCID
  2. Priyanshu Bharadwaj: UFR des Sciences de Santé, Université de Bourgogne Franche-Comté, 21000 Dijon, France. ORCID
  3. Muhammad Bilal: School of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian 223003, China. ORCID
  4. Mahmood Barani: Department of Chemistry, Shahid Bahonar University of Kerman, Kerman 76175-133, Iran.
  5. Abbas Rahdar: Department of Physics, University of Zabol, Zabol 98613-35856, Iran. ORCID
  6. Pablo Taboada: Colloids and Polymers Physics Group, Condensed Matter Physics Area, Particle Physics Department Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
  7. Simona Bungau: Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.
  8. George Z Kyzas: Department of Chemistry, International Hellenic University, 65404 Kavala, Greece. ORCID

Abstract

In the past few decades, polymeric nanocarriers have been recognized as promising tools and have gained attention from researchers for their potential to efficiently deliver bioactive compounds, including drugs, proteins, genes, nucleic acids, etc., in pharmaceutical and biomedical applications. Remarkably, these polymeric nanocarriers could be further modified as stimuli-responsive systems based on the mechanism of triggered release, i.e., response to a specific stimulus, either endogenous (pH, enzymes, temperature, redox values, hypoxia, glucose levels) or exogenous (light, magnetism, ultrasound, electrical pulses) for the effective biodistribution and controlled release of drugs or genes at specific sites. Various nanoparticles (NPs) have been functionalized and used as templates for imaging systems in the form of metallic NPs, dendrimers, polymeric NPs, quantum dots, and liposomes. The use of polymeric nanocarriers for imaging and to deliver active compounds has attracted considerable interest in various cancer therapy fields. So-called smart nanopolymer systems are built to respond to certain stimuli such as temperature, pH, light intensity and wavelength, and electrical, magnetic and ultrasonic fields. Many imaging techniques have been explored including optical imaging, magnetic resonance imaging (MRI), nuclear imaging, ultrasound, photoacoustic imaging (PAI), single photon emission computed tomography (SPECT), and positron emission tomography (PET). This review reports on the most recent developments in imaging methods by analyzing examples of smart nanopolymers that can be imaged using one or more imaging techniques. Unique features, including nontoxicity, water solubility, biocompatibility, and the presence of multiple functional groups, designate polymeric nanocues as attractive nanomedicine candidates. In this context, we summarize various classes of multifunctional, polymeric, nano-sized formulations such as liposomes, micelles, nanogels, and dendrimers.

Keywords

References

  1. ACS Appl Mater Interfaces. 2015 May 13;7(18):9410-9 [PMID: 25881356]
  2. ACS Nano. 2012 Apr 24;6(4):3491-8 [PMID: 22409425]
  3. Curr Pharm Des. 2002;8(20):1781-807 [PMID: 12171531]
  4. J Biomed Mater Res B Appl Biomater. 2018 Aug;106(6):2169-2176 [PMID: 29052337]
  5. Free Radic Biol Med. 2001 Jun 1;30(11):1191-212 [PMID: 11368918]
  6. Cancer Res. 1989 Dec 1;49(23):6449-65 [PMID: 2684393]
  7. Chem Commun (Camb). 2011 Sep 7;47(33):9459-61 [PMID: 21779606]
  8. Nat Methods. 2012 May 13;9(7):749-54 [PMID: 22581372]
  9. J Control Release. 2016 Mar 28;226:168-81 [PMID: 26892751]
  10. Biomaterials. 2012 Sep;33(27):6570-9 [PMID: 22704845]
  11. Nanoscale Res Lett. 2019 Jan 16;14(1):24 [PMID: 30649655]
  12. Biomaterials. 2014 Jul;35(22):5932-43 [PMID: 24746965]
  13. Theranostics. 2019 May 31;9(14):4168-4181 [PMID: 31281539]
  14. J Control Release. 2015 Jan 28;198:35-54 [PMID: 25481448]
  15. Gels. 2018 Feb 01;4(1): [PMID: 30674789]
  16. ACS Nano. 2010 Jan 26;4(1):251-8 [PMID: 20039697]
  17. Chem Soc Rev. 2019 Jan 2;48(1):38-71 [PMID: 30387803]
  18. Int J Nanomedicine. 2019 Nov 29;14:9309-9324 [PMID: 31819433]
  19. ACS Macro Lett. 2014 Nov 18;3(11):1210-1214 [PMID: 35610827]
  20. Bioconjug Chem. 2005 Nov-Dec;16(6):1423-32 [PMID: 16287238]
  21. J Biomed Mater Res A. 2003 Aug 1;66(2):347-55 [PMID: 12889005]
  22. Pharm Res. 2010 Jan;27(1):161-74 [PMID: 19862607]
  23. Biomacromolecules. 2020 Jul 13;21(7):2681-2694 [PMID: 32433878]
  24. Int J Biol Macromol. 2019 Feb 15;123:968-978 [PMID: 30448487]
  25. J Control Release. 2001 May 18;73(1):89-102 [PMID: 11337062]
  26. Front Biosci. 2008 Jan 01;13:1447-71 [PMID: 17981642]
  27. Biomaterials. 2011 Jul;32(21):4976-86 [PMID: 21486679]
  28. Int J Pharm. 2008 Nov 3;363(1-2):170-6 [PMID: 18687392]
  29. Colloids Surf B Biointerfaces. 2014 Nov 1;123:657-63 [PMID: 25456989]
  30. Int J Pharm. 2002 Dec 5;249(1-2):127-38 [PMID: 12433441]
  31. Adv Healthc Mater. 2019 Jun;8(12):e1801466 [PMID: 30605265]
  32. Theranostics. 2016 Jun 05;6(9):1293-305 [PMID: 27375780]
  33. Chem Rev. 2018 Jul 25;118(14):6844-6892 [PMID: 29957926]
  34. N Engl J Med. 1995 Sep 28;333(13):871-3 [PMID: 7651480]
  35. Colloids Surf B Biointerfaces. 2015 Dec 1;136:712-20 [PMID: 26513754]
  36. Mol Pharm. 2017 May 1;14(5):1450-1459 [PMID: 28277671]
  37. J Biomater Sci Polym Ed. 2016;27(1):40-54 [PMID: 26489768]
  38. Chempluschem. 2019 Aug;84(8):1135-1139 [PMID: 31943967]
  39. Nat Rev Cancer. 2002 Oct;2(10):750-63 [PMID: 12360278]
  40. J Control Release. 2011 Oct 10;155(1):96-103 [PMID: 21075151]
  41. J Dent Res. 2019 May;98(5):564-571 [PMID: 30876379]
  42. Int J Nanomedicine. 2015 Aug 28;10:5489-503 [PMID: 26357473]
  43. Polymers (Basel). 2017 Dec 11;9(12): [PMID: 30965997]
  44. Eur J Pharm Biopharm. 2015 May;92:146-54 [PMID: 25753198]
  45. Biomacromolecules. 2019 Feb 11;20(2):790-800 [PMID: 30563327]
  46. Curr Pharm Des. 2020;26(11):1167-1180 [PMID: 32026769]
  47. Bioconjug Chem. 2020 Mar 18;31(3):907-915 [PMID: 32096990]
  48. Chem Pharm Bull (Tokyo). 2017 Dec 1;65(12):1132-1143 [PMID: 29021499]
  49. J Am Chem Soc. 2016 May 11;138(18):5777-80 [PMID: 27120207]
  50. Eur J Pharm Sci. 2018 Sep 15;122:179-184 [PMID: 29981402]
  51. Front Chem. 2020 Mar 20;8:203 [PMID: 32266217]
  52. Cell. 2010 Apr 2;141(1):52-67 [PMID: 20371345]
  53. J Control Release. 2005 Jan 20;102(1):203-22 [PMID: 15653146]
  54. Biomater Sci. 2019 Apr 23;7(5):1962-1972 [PMID: 30810135]
  55. Nanoscale. 2017 Jan 7;9(1):143-149 [PMID: 27929180]
  56. Colloids Surf B Biointerfaces. 2019 Jan 1;173:698-708 [PMID: 30384266]
  57. J Pharm Sci. 2008 Jan;97(1):123-43 [PMID: 17721949]
  58. Chem Rev. 2011 Dec 14;111(12):7855-75 [PMID: 21902252]
  59. Biomaterials. 2014 Jun;35(19):5148-61 [PMID: 24680663]
  60. Biomaterials. 2006 Mar;27(8):1586-97 [PMID: 16139881]
  61. J Cell Physiol. 2020 Oct;235(10):6817-6830 [PMID: 31989649]
  62. Chem Commun (Camb). 2010 Jun 21;46(23):4094-6 [PMID: 20464018]
  63. Drug Deliv. 2017 Nov;24(1):569-581 [PMID: 28195032]
  64. Biomaterials. 2016 Feb;79:88-100 [PMID: 26702587]
  65. Int J Biol Macromol. 2019 Nov 1;140:255-264 [PMID: 31421175]
  66. iScience. 2019 Dec 20;22:229-239 [PMID: 31786519]
  67. Mater Sci Eng C Mater Biol Appl. 2018 Oct 1;91:606-614 [PMID: 30033293]
  68. Acta Biomater. 2016 Oct 15;44:341-54 [PMID: 27545812]
  69. Cancer Chemother Pharmacol. 2013 Mar;71(3):555-64 [PMID: 23212117]
  70. Expert Rev Vaccines. 2008 Oct;7(8):1141-50 [PMID: 18844588]
  71. J Pharm Sci. 1992 Jun;81(6):532-6 [PMID: 1522489]
  72. Chem Commun (Camb). 2019 May 28;55(44):6209-6212 [PMID: 31073580]
  73. Biomacromolecules. 2011 Oct 10;12(10):3684-91 [PMID: 21863834]
  74. Int J Biol Macromol. 2018 Apr 15;110:399-405 [PMID: 29133095]
  75. Biotechnol Bioeng. 2006 Oct 20;95(3):333-41 [PMID: 16894636]
  76. Biomaterials. 2018 Oct;180:240-252 [PMID: 30055399]
  77. Nat Mater. 2010 Nov;9(11):923-8 [PMID: 20935658]
  78. J Control Release. 2009 Sep 15;138(3):268-76 [PMID: 19477208]
  79. Bioact Mater. 2016 Dec;1(2):93-108 [PMID: 28653043]
  80. AAPS J. 2007 May 11;9(2):E128-47 [PMID: 17614355]
  81. J Control Release. 2000 Oct 3;69(1):127-37 [PMID: 11018551]
  82. Bioconjug Chem. 2015 Mar 18;26(3):582-92 [PMID: 25710619]
  83. Cancer. 1987 May 1;59(9):1560-5 [PMID: 3030530]
  84. Science. 1978 Dec 22;202(4374):1290-3 [PMID: 364652]
  85. Sci Transl Med. 2018 Feb 21;10(429): [PMID: 29467299]
  86. J Control Release. 2003 Jan 9;86(1):115-21 [PMID: 12490377]
  87. Ultrasonics. 2019 Nov;99:105947 [PMID: 31284166]
  88. Spectrochim Acta A Mol Biomol Spectrosc. 2019 Jan 15;207:321-327 [PMID: 30267977]
  89. J Control Release. 2018 Dec 28;292:67-77 [PMID: 29723611]
  90. Trends Pharmacol Sci. 2009 Nov;30(11):592-9 [PMID: 19837467]
  91. J Nucl Med. 2014 Dec;55(12):1919-22 [PMID: 25413134]
  92. J Biomed Mater Res A. 2004 Jan 1;68(1):71-8 [PMID: 14661251]
  93. Colloids Surf B Biointerfaces. 2011 Oct 15;87(2):454-63 [PMID: 21719259]
  94. Curr Pharm Des. 2019;25(4):424-443 [PMID: 30947654]
  95. Nat Mater. 2013 Nov;12(11):991-1003 [PMID: 24150417]
  96. Pharm Res. 2010 Jun;27(6):999-1013 [PMID: 20354764]
  97. Chem Commun (Camb). 2018 Oct 2;54(79):11092-11095 [PMID: 30175824]
  98. J Control Release. 2007 Oct 18;123(1):19-26 [PMID: 17826863]
  99. Pharmaceutics. 2017 Mar 27;9(2): [PMID: 28346375]
  100. Int J Nanomedicine. 2019 Jun 11;14:4367-4381 [PMID: 31354266]
  101. Exp Biol Med (Maywood). 2014 May 8;239(7):779-792 [PMID: 24812122]
  102. Cancer Immunol Immunother. 2007 Aug;56(8):1215-23 [PMID: 17219149]
  103. J Nanobiotechnology. 2020 Jun 5;18(1):85 [PMID: 32503549]
  104. J Biomed Nanotechnol. 2015 Dec;11(12):2124-36 [PMID: 26510307]
  105. Colloids Surf B Biointerfaces. 2019 Mar 1;175:392-402 [PMID: 30554018]
  106. Sci Rep. 2019 Oct 17;9(1):14912 [PMID: 31624285]
  107. Pharm Res. 2014 Jan;31(1):20-34 [PMID: 23896738]
  108. Biomaterials. 2013 May;34(14):3647-57 [PMID: 23415642]
  109. Adv Mater. 2015 Oct 7;27(37):5484-92 [PMID: 26265592]
  110. J Control Release. 2018 Jun 10;279:147-156 [PMID: 29653223]
  111. J Am Chem Soc. 2019 Dec 11;141(49):19221-19225 [PMID: 31746598]
  112. Nanoscale. 2019 Jun 20;11(24):11617-11625 [PMID: 31173027]
  113. Biomater Sci. 2018 Nov 1;6(11):2838-2849 [PMID: 30229771]
  114. J Pharm Pharmacol. 2002 Oct;54(10):1323-8 [PMID: 12396292]
  115. Bioconjug Chem. 2011 Oct 19;22(10):1939-45 [PMID: 21866903]
  116. Adv Funct Mater. 2017 Apr 5;27(13): [PMID: 29046623]
  117. Acta Biomater. 2018 Jul 15;75:312-322 [PMID: 29885530]
  118. Macromol Biosci. 2010 Mar 10;10(3):239-45 [PMID: 19924685]
  119. JAMA. 2006 May 17;295(19):2275-85 [PMID: 16705109]
  120. Bioconjug Chem. 2001 Jul-Aug;12(4):529-37 [PMID: 11459457]
  121. Nano Lett. 2016 Apr 13;16(4):2556-9 [PMID: 27035761]
  122. Nanomicro Lett. 2020 Feb 4;12(1):47 [PMID: 34138253]
  123. J Mater Sci Mater Med. 2007 Sep;18(9):1665-74 [PMID: 17483879]
  124. Expert Opin Biol Ther. 2007 May;7(5):587-93 [PMID: 17477797]
  125. Curr Med Chem. 2020;27(16):2631-2657 [PMID: 31755377]
  126. Adv Drug Deliv Rev. 2006 Dec 30;58(15):1622-54 [PMID: 17123658]
  127. Tissue Eng Part A. 2010 Feb;16(2):695-703 [PMID: 19769528]
  128. Biomed Mater. 2013 Apr;8(2):025012 [PMID: 23507576]
  129. Int J Mol Sci. 2019 Oct 09;20(20): [PMID: 31600975]
  130. Theranostics. 2012;2(12):1117-26 [PMID: 23382770]
  131. Med Res Rev. 2005 Sep;25(5):490-520 [PMID: 16025498]
  132. ACS Omega. 2019 Sep 12;4(13):15567-15580 [PMID: 31572858]
  133. Macromol Biosci. 2011 Sep 9;11(9):1264-71 [PMID: 21717576]
  134. Biomacromolecules. 2014 Feb 10;15(2):628-34 [PMID: 24432713]
  135. J Pharm Sci. 2005 Jan;94(1):184-98 [PMID: 15761942]
  136. Int J Nanomedicine. 2006;1(3):297-315 [PMID: 17717971]
  137. Curr Drug Deliv. 2020;17(10):845-860 [PMID: 32294036]
  138. J Control Release. 2017 Jul 28;258:196-207 [PMID: 28445743]
  139. Mater Sci Eng C Mater Biol Appl. 2019 Dec;105:110107 [PMID: 31546448]
  140. Chem Commun (Camb). 2015 Jan 11;51(3):465-8 [PMID: 25327260]
  141. Int J Nanomedicine. 2017 Feb 08;12:1065-1083 [PMID: 28223799]
  142. Science. 2004 Mar 19;303(5665):1818-22 [PMID: 15031496]
  143. Int J Pharm. 2010 Dec 15;402(1-2):231-7 [PMID: 20934501]
  144. Angew Chem Int Ed Engl. 2014 Nov 10;53(46):12436-40 [PMID: 25044856]
  145. ACS Appl Mater Interfaces. 2019 Aug 28;11(34):31302-31310 [PMID: 31369228]
  146. ACS Nano. 2012 May 22;6(5):4279-87 [PMID: 22471841]
  147. Nat Rev Drug Discov. 2011 Sep 16;10(10):767-77 [PMID: 21921921]
  148. Int J Biol Macromol. 2012 Nov;51(4):566-75 [PMID: 22743347]
  149. J Pharm Sci. 2016 Mar;105(3):1104-12 [PMID: 26886332]
  150. Nat Rev Drug Discov. 2014 Nov;13(11):813-27 [PMID: 25287120]
  151. Macromol Biosci. 2017 Jan;17(1): [PMID: 27739631]
  152. Angew Chem Int Ed Engl. 2009;48(18):3329-32 [PMID: 19343743]
  153. Acta Biomater. 2017 Jun;55:153-162 [PMID: 28259838]
  154. Ultrasonography. 2017 Jul;36(3):171-184 [PMID: 28607323]
  155. Chem Rev. 2001 Dec;101(12):3819-68 [PMID: 11740922]
  156. Chem Rev. 2015 Oct 14;115(19):10967-1011 [PMID: 26463640]
  157. Biomolecules. 2019 Nov 27;9(12): [PMID: 31783573]
  158. Int J Pharm. 2002 Mar 20;235(1-2):43-50 [PMID: 11879738]
  159. J Biomed Mater Res A. 2013 Sep;101(9):2644-60 [PMID: 23413041]
  160. Sci Rep. 2015 May 11;5:10099 [PMID: 25959874]
  161. Int J Pharm. 2011 Sep 15;416(1):104-9 [PMID: 21704139]
  162. Mater Sci Eng C Mater Biol Appl. 2020 Apr;109:110524 [PMID: 32228960]
  163. J Control Release. 2016 Jan 28;222:56-66 [PMID: 26682502]
  164. Adv Healthc Mater. 2020 Mar;9(5):e1901616 [PMID: 31990442]
  165. J Drug Target. 2020 Mar;28(3):245-258 [PMID: 31462111]
  166. Acta Biomater. 2020 May;108:97-110 [PMID: 32165193]
  167. J Control Release. 2018 Oct 28;288:14-22 [PMID: 30170068]
  168. Biomacromolecules. 2019 Jan 14;20(1):546-557 [PMID: 30521313]
  169. Polymers (Basel). 2020 Mar 09;12(3): [PMID: 32182870]
  170. Nanoscale. 2015 Mar 7;7(9):3888-902 [PMID: 25422147]
  171. J Mater Chem B. 2020 Aug 12;8(31):6912-6924 [PMID: 32432602]
  172. J Mater Chem B. 2018 Jun 7;6(21):3531-3540 [PMID: 32254448]
  173. Biomaterials. 2016 Jun;90:12-26 [PMID: 26974704]
  174. Mol Pharm. 2005 Sep-Oct;2(5):357-66 [PMID: 16196488]
  175. Cancer Res. 2006 Jul 1;66(13):6732-40 [PMID: 16818648]
  176. Macromol Biosci. 2011 Dec 8;11(12):1736-46 [PMID: 22028095]
  177. Adv Mater. 2020 Jan;32(2):e1906711 [PMID: 31773830]
  178. J Neurol Sci. 2004 Sep 15;224(1-2):77-82 [PMID: 15450774]
  179. Nanomedicine. 2018 Apr;14(3):713-723 [PMID: 29317344]
  180. Biomater Sci. 2018 Feb 27;6(3):511-518 [PMID: 29369308]
  181. AAPS PharmSciTech. 2017 Aug;18(6):2026-2036 [PMID: 27966176]
  182. Bioconjug Chem. 2019 Jun 19;30(6):1649-1657 [PMID: 31136151]
  183. J Biosci Bioeng. 2005 Jul;100(1):1-11 [PMID: 16233845]
  184. Int J Pharm. 2012 Sep 15;434(1-2):384-90 [PMID: 22683455]
  185. Acc Chem Res. 2012 Oct 16;45(10):1817-27 [PMID: 22950890]
  186. Molecules. 2019 Jul 12;24(14): [PMID: 31336916]
  187. ACS Nano. 2012 May 22;6(5):4001-12 [PMID: 22533614]
  188. Biomacromolecules. 2008 Jun;9(6):1558-70 [PMID: 18481893]
  189. Nano Lett. 2019 Feb 13;19(2):1216-1226 [PMID: 30698017]
  190. Nanomedicine. 2007 Mar;3(1):32-42 [PMID: 17379167]
  191. Mar Drugs. 2019 Jan 10;17(1): [PMID: 30634710]
  192. ACS Appl Mater Interfaces. 2014 Dec 24;6(24):21859-73 [PMID: 25014486]
  193. ACS Nano. 2011 Mar 22;5(3):2162-75 [PMID: 21314184]
  194. ACS Nano. 2013 Aug 27;7(8):6758-66 [PMID: 23834678]
  195. ACS Appl Mater Interfaces. 2018 Feb 14;10(6):5318-5330 [PMID: 29355017]
  196. Antimicrob Agents Chemother. 2015 Apr;59(4):2215-22 [PMID: 25645853]
  197. Artif Cells Nanomed Biotechnol. 2018;46(sup3):S911-S921 [PMID: 30307331]
  198. ACS Nano. 2019 Jul 23;13(7):7750-7758 [PMID: 31244043]
  199. Mater Sci Eng C Mater Biol Appl. 2019 May;98:9-18 [PMID: 30813097]
  200. J Photochem Photobiol B. 2020 Jan;202:111716 [PMID: 31821944]
  201. Mater Sci Eng C Mater Biol Appl. 2016 May;62:113-22 [PMID: 26952404]
  202. Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:1121-1128 [PMID: 28482476]
  203. ACS Appl Mater Interfaces. 2017 Aug 9;9(31):25706-25716 [PMID: 28741924]
  204. Bioconjug Chem. 2006 Nov-Dec;17(6):1464-72 [PMID: 17105225]
  205. J Control Release. 2018 Apr 28;276:59-71 [PMID: 29501533]
  206. Cancer Res. 2007 May 15;67(10):4843-50 [PMID: 17510414]
  207. Pharm Res. 2005 Dec;22(12):2107-14 [PMID: 16254763]
  208. Mater Sci Eng C Mater Biol Appl. 2019 Oct;103:109803 [PMID: 31349440]
  209. Int J Nanomedicine. 2019 Sep 30;14:7933-7946 [PMID: 31686819]
  210. Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):4465-4470 [PMID: 29626132]
  211. Expert Opin Drug Deliv. 2006 May;3(3):311-24 [PMID: 16640493]
  212. Adv Mater. 2015 Oct 7;27(37):5547-52 [PMID: 26305446]
  213. Science. 1972 Sep 15;177(4053):949-59 [PMID: 5055944]
  214. J Control Release. 2011 May 30;152(1):2-12 [PMID: 21295087]
  215. Mater Sci Eng C Mater Biol Appl. 2017 Apr 1;73:189-197 [PMID: 28183597]
  216. Circ Res. 2016 Aug 5;119(4):511-3 [PMID: 27492841]
  217. Pharm Res. 2020 Mar 12;37(3):65 [PMID: 32166361]
  218. Angew Chem Int Ed Engl. 2014 Mar 24;53(13):3362-6 [PMID: 24554550]
  219. Pharm Res. 2006 Jul;23(7):1417-50 [PMID: 16779701]
  220. Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):125-48 [PMID: 11259837]
  221. Sci Technol Adv Mater. 2015 May 8;16(3):034604 [PMID: 27877791]
  222. Biomacromolecules. 2016 Aug 8;17(8):2507-13 [PMID: 27303825]
  223. Adv Mater. 2011 Oct 18;23(39):4549-53 [PMID: 21910141]
  224. Ultrasonography. 2016 Oct;35(4):267-80 [PMID: 27669961]
  225. ACS Nano. 2016 Apr 26;10(4):4472-81 [PMID: 26959505]
  226. J Mater Chem B. 2013 Jun 28;1(24):3002-3025 [PMID: 32261003]
  227. Int J Pharm. 2019 Aug 15;567:118486 [PMID: 31260783]
  228. J Drug Target. 2002 Nov;10(7):549-56 [PMID: 12683722]
  229. Pharmaceutics. 2020 Feb 18;12(2): [PMID: 32085488]
  230. ACS Nano. 2013 May 28;7(5):3912-25 [PMID: 23590591]
  231. J Mater Chem B. 2020 Mar 11;8(10):2115-2122 [PMID: 32073099]
  232. Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):17047-52 [PMID: 24062440]
  233. Biomaterials. 2010 Feb;31(5):988-97 [PMID: 19850338]
  234. Contrast Media Mol Imaging. 2019 Jun 10;2019:8085039 [PMID: 31281235]
  235. J Colloid Interface Sci. 2019 Sep 1;551:1-9 [PMID: 31071490]
  236. ACS Nano. 2015 Mar 24;9(3):2377-89 [PMID: 25703655]
  237. Nanoscale Horiz. 2016 Nov 17;1(6):480-487 [PMID: 32260712]
  238. Ultrasound Med Biol. 2019 Jan;45(1):160-169 [PMID: 30482711]
  239. FASEB J. 2005 Mar;19(3):311-30 [PMID: 15746175]
  240. Technol Cancer Res Treat. 2005 Dec;4(6):615-25 [PMID: 16292881]
  241. Biomaterials. 2014 Jul;35(21):5627-35 [PMID: 24731711]
  242. Adv Drug Deliv Rev. 2003 Feb 10;55(2):199-215 [PMID: 12564977]
  243. Pharm Res. 2002 Jul;19(7):1061-7 [PMID: 12180540]
  244. Colloids Surf B Biointerfaces. 2019 May 1;177:425-432 [PMID: 30798063]
  245. Carbohydr Polym. 2012 Sep 1;90(1):361-9 [PMID: 24751053]
  246. J Control Release. 2001 Jul 6;74(1-3):213-24 [PMID: 11489497]
  247. J Colloid Interface Sci. 2018 Mar 15;514:517-527 [PMID: 29289734]
  248. Trends Biotechnol. 1997 Jun;15(6):217-24 [PMID: 9183864]
  249. Membranes (Basel). 2018 Jan 03;8(1): [PMID: 29301357]
  250. Nano Lett. 2011 Mar 9;11(3):1284-8 [PMID: 21280644]
  251. Biomaterials. 2014 Apr;35(13):4213-22 [PMID: 24529391]
  252. Biomacromolecules. 2020 Jun 8;21(6):2024-2031 [PMID: 32364721]
  253. J Control Release. 2011 Jul 30;153(2):187-94 [PMID: 21501640]
  254. Theranostics. 2018 Feb 2;8(5):1327-1339 [PMID: 29507623]
  255. Biochim Biophys Acta. 2003 Jun 27;1613(1-2):28-38 [PMID: 12832084]
  256. Langmuir. 2010 Jan 19;26(2):709-15 [PMID: 19627165]
  257. Adv Healthc Mater. 2017 Mar;6(6): [PMID: 28218487]
  258. ACS Nano. 2015 Nov 24;9(11):11023-33 [PMID: 26456489]
  259. Nucl Med Mol Imaging. 2019 Aug;53(4):242-246 [PMID: 31456856]
  260. Colloids Surf B Biointerfaces. 2019 Feb 1;174:416-425 [PMID: 30481702]
  261. ACS Nano. 2011 Nov 22;5(11):9246-55 [PMID: 22011045]
  262. Pharm Res. 1991 Apr;8(4):531-7 [PMID: 1871053]
  263. J Mater Chem B. 2020 Jan 28;8(4):592-606 [PMID: 31939473]
  264. Biochem Biophys Res Commun. 1981 Oct 15;102(3):1048-54 [PMID: 7306187]
  265. ACS Nano. 2012 Jan 24;6(1):227-33 [PMID: 22111891]
  266. Adv Drug Deliv Rev. 2017 Sep 15;119:61-72 [PMID: 28802567]
  267. Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:53-61 [PMID: 28024618]
  268. Mol Pharm. 2016 Jun 6;13(6):1750-62 [PMID: 27100204]
  269. Macromol Biosci. 2005 Feb 23;5(2):107-11 [PMID: 15719428]
  270. Adv Biosyst. 2017 Sep;1(9):e1700084 [PMID: 32646189]
  271. Adv Mater. 2014 Apr 16;26(15):2398-402 [PMID: 24375889]
  272. J Pharm Pharm Sci. 2008;11(4):32-45 [PMID: 19183512]
  273. J Liposome Res. 2007;17(1):1-14 [PMID: 17454399]
  274. J Control Release. 2017 Sep 10;261:126-137 [PMID: 28666728]
  275. Int J Biol Macromol. 2020 Apr 15;149:809-818 [PMID: 31958558]
  276. J Mater Chem B. 2013 Sep 28;1(36):4593-4600 [PMID: 32261202]
  277. Adv Drug Deliv Rev. 2012 Aug;64(11):967-78 [PMID: 22266127]
  278. Adv Drug Deliv Rev. 2019 Apr;144:57-77 [PMID: 31400350]
  279. ACS Appl Mater Interfaces. 2019 Jul 10;11(27):24377-24385 [PMID: 31195793]
  280. Materials (Basel). 2017 Feb 13;10(2): [PMID: 28772528]

Word Cloud

Created with Highcharts 10.0.0imagingpolymericnanocarriersincludingstimuli-responsivesystemsNPsstimulidelivercompoundsdrugsgenesreleasespecificendogenouspHtemperatureexogenouslightultrasoundelectricaldendrimersliposomesvariousfieldssmartmagnetictechniquesemissiontomographypastdecadesrecognizedpromisingtoolsgainedattentionresearcherspotentialefficientlybioactiveproteinsnucleicacidsetcpharmaceuticalbiomedicalapplicationsRemarkablymodifiedbasedmechanismtriggeredieresponsestimuluseitherenzymesredoxvalueshypoxiaglucoselevelsmagnetismpulseseffectivebiodistributioncontrolledsitesVariousnanoparticlesfunctionalizedusedtemplatesformmetallicquantumdotsuseactiveattractedconsiderableinterestcancertherapySo-callednanopolymerbuiltrespondcertainintensitywavelengthultrasonicManyexploredopticalresonanceMRInuclearphotoacousticPAIsinglephotoncomputedSPECTpositronPETreviewreportsrecentdevelopmentsmethodsanalyzingexamplesnanopolymerscanimagedusingoneUniquefeaturesnontoxicitywatersolubilitybiocompatibilitypresencemultiplefunctionalgroupsdesignatenanocuesattractivenanomedicinecandidatescontextsummarizeclassesmultifunctionalnano-sizedformulationsmicellesnanogelsStimuli-ResponsivePolymericNanocarriersDrugDeliveryImagingTheragnosisdrugdeliverytargetingtheranostic

Similar Articles

Cited By